Academic Palliative Care

学术姑息治疗

基本信息

批准号：
7269523
负责人：
CHARLES F VON GUNTEN
金额：
$ 14.41万
依托单位：
SAN DIEGO HOSPICE AND PALLIATIVE CARE
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-09-01 至 2009-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7269523
关键词：
Acupuncture procedure Address Advocacy American Appendix Area Attitude California Chairperson Commit Communication Competence Comprehensive Cancer Center Development Distress Doctor of Philosophy Education Educational Curriculum Educational process of instructing Evaluation Faculty Family Fostering Funding Future Goals Grant Hospice Care Hour Institute of Medicine (U.S.)Internal Medicine Intractable Pain Journals Knowledge Leadership Legal Lidocaine Malignant Neoplasms Measures Medical Education Medical Students Mentors Methods Modeling National Cancer Institute National Cancer Policy Board Nurse Practitioners Nurses Outcome Palliative Care Palliative Medicine Patient Care Patient Self-Report Patients Pattern Physicians Positioning Attribute Prevention Prevention approach Publications Range Reporting Research Research Design Research Infrastructure Research Peer Review Research Personnel Role Rotation Scientist Score Social Workers Students Support of Research Symptoms Terminal Disease Testing Time Training Universities Week cancer therapy day enteropathogenic Escherichia coli hospice environment improved instrument interest medical schools member painful neuropathy programs research and development skills university student

项目摘要

DESCRIPTION (provided by applicant): Charles F. von Gunten, MD, PhD is seeking support as an established investigator in palliative care, part of National Cancer Institute's prevention and control program. Palliative care can be summarized as the prevention and relief of suffering. As an established investigator with a track record of funded research, peer-reviewed publications and mentoring, he is now in a unique position to foster further development of the field as called for in the recent reports by the Institute of Medicine and National Cancer Policy Board. In roles as Director of the Center for Palliative Studies at San Diego Hospice & Palliative Care, a teaching and research affiliate of the University of California San Diego School of Medicine, member of the NCI-designated University of California San Diego Moores Comprehensive Cancer Center, Co-Principal of the EPEC Project, Senior Associate Editor of the Journal of Palliative Medicine and Chairman, American Board of Hospice and Palliative Medicine, the NCI is able to protect his abilities to conduct palliative care research and mentor trainees and leaders in the field. He has pursued research objectives to understand education (particularly physicians) and symptom control (particularly neuropathic pain) and as well as broad advocacy and leadership objectives to achieve his goals. Scientifically supported approaches to the prevention and relief of suffering are as important to the overall care of patients with cancer and their families as are approaches to the treatment of cancer itself. He needs protected time to continue a vital research program in the creation and dissemination of palliative care knowledge and reentering new physician scientists in the field. He is responsible for the educational and research developments in the largest department of subspecialist palliative medicine physicians in the USA. In addition, he is responsible for nurturing and developing nurse practitioners, nurses, social workers, and chaplains in a similar way. His personal research plan addresses the question "How is palliative care best taught?" This K05 will permit him to conduct educational research for resident physicians, physician fellows, nurses, social workers and chaplains. This K05 will permit him to mentor junior investigators in projects to test the ability of infusional lidocaine to relieve severe refractory pain, to understand patient, family, staff communication in terminal illness, and to test the ability of acupuncture to relieve distress in patients with terminal illness. All reentered investigators are seeking NCI funding and have the potential to become independent investigators.

描述（由申请人提供）：Charles F. Von Gunten，医学博士，博士正在寻求支持，作为姑息治疗的既定研究者，这是国家癌症研究所预防和控制计划的一部分。可以将姑息治疗总结为预防和缓解痛苦。作为一名知名研究人员，具有资助研究，同行评审的出版物和指导的记录，他现在处于独特的地位，可以在医学和国家癌症政策委员会最近的报告中促进该领域的进一步发展。在圣地亚哥临终关怀和姑息治疗中心担任姑息研究中心主任，加利福尼亚大学圣地亚哥大学医学院的教学和研究分支机构，NCI指定的加利福尼亚州圣地亚哥摩尔斯大学综合癌症中心，EPEC综合项目，美国专家医学杂志，美国专家委员会，美国国家杂志，保护他的能力进行姑息治疗研究和指导学员和领导者。他追求研究目标，以了解教育（尤其是医师）和症状控制（尤其是神经性疼痛），以及广泛的倡导和领导目标以实现其目标。科学支持的预防和缓解痛苦的方法对于癌症患者及其家人的整体护理和治疗癌症本身的方法一样重要。他需要受到保护的时间来继续进行重要的研究计划，以创建和传播姑息治疗知识并重新进入该领域的新医师科学家。他负责美国最大的专科姑息医学医学部门的教育和研究发展。此外，他负责以类似的方式培养和发展护士从业者，护士，社会工作者和牧师。他的个人研究计划解决了一个问题：“如何最好地教授姑息治疗？”该K05将使他能够为居民医师，医师，护士，社会工作者和牧师进行教育研究。该K05将使他能够指导初级调查人员的项目，以测试输液利多卡因缓解严重难治性疼痛的能力，了解患者，家庭，绝症中的员工沟通，并测试针灸减轻绝症患者痛苦的能力。所有重新进入的调查人员都在寻求NCI资金，并有可能成为独立研究人员。